116 related articles for article (PubMed ID: 16279790)
1. Synthesis and biological activity of anticancer ether lipids that are specifically released by phospholipase A2 in tumor tissue.
Andresen TL; Jensen SS; Madsen R; Jørgensen K
J Med Chem; 2005 Nov; 48(23):7305-14. PubMed ID: 16279790
[TBL] [Abstract][Full Text] [Related]
2. Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs.
Andresen TL; Davidsen J; Begtrup M; Mouritsen OG; Jørgensen K
J Med Chem; 2004 Mar; 47(7):1694-703. PubMed ID: 15027860
[TBL] [Abstract][Full Text] [Related]
3. Secretory phospholipase A2 as a tumor-specific trigger for targeted delivery of a novel class of liposomal prodrug anticancer etherlipids.
Jensen SS; Andresen TL; Davidsen J; Høyrup P; Shnyder SD; Bibby MC; Gill JH; Jørgensen K
Mol Cancer Ther; 2004 Nov; 3(11):1451-8. PubMed ID: 15542784
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biophysical characterization of chlorambucil anticancer ether lipid prodrugs.
Pedersen PJ; Christensen MS; Ruysschaert T; Linderoth L; Andresen TL; Melander F; Mouritsen OG; Madsen R; Clausen MH
J Med Chem; 2009 May; 52(10):3408-15. PubMed ID: 19402667
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of a fluorinated analogue of anticancer active ether lipids.
Burchardt A; Takahashi T; Takeuchi Y; Haufe G
J Org Chem; 2001 Mar; 66(6):2078-84. PubMed ID: 11300904
[TBL] [Abstract][Full Text] [Related]
6. Triggered activation and release of liposomal prodrugs and drugs in cancer tissue by secretory phospholipase A2.
Andresen TL; Jensen SS; Kaasgaard T; Jørgensen K
Curr Drug Deliv; 2005 Oct; 2(4):353-62. PubMed ID: 16305438
[TBL] [Abstract][Full Text] [Related]
7. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release.
Andresen TL; Jensen SS; Jørgensen K
Prog Lipid Res; 2005 Jan; 44(1):68-97. PubMed ID: 15748655
[TBL] [Abstract][Full Text] [Related]
8. [Ether lipids--a new structural class of antineoplastic compounds].
Kovar A; Grauer C; Zimmermann W
Pharmazie; 1994 Jul; 49(7):471-9. PubMed ID: 8073056
[No Abstract] [Full Text] [Related]
9. [Ether lipids--synthesis and application in tumor therapy].
Zeisig R; Arndt D; Brachwitz H
Pharmazie; 1990 Nov; 45(11):809-18. PubMed ID: 2100332
[No Abstract] [Full Text] [Related]
10. Phospholipase A(2)-susceptible liposomes of anticancer double lipid-prodrugs.
Arouri A; Mouritsen OG
Eur J Pharm Sci; 2012 Mar; 45(4):408-20. PubMed ID: 21946258
[TBL] [Abstract][Full Text] [Related]
11. In vitro optimization of non-small cell lung cancer activity with troxacitabine, L-1,3-dioxolane-cytidine, prodrugs.
Radi M; Adema AD; Daft JR; Cho JH; Hoebe EK; Alexander LE; Peters GJ; Chu CK
J Med Chem; 2007 May; 50(9):2249-53. PubMed ID: 17419604
[TBL] [Abstract][Full Text] [Related]
12. Parallel fragment assembly strategy towards multiple-ether mimicry of anticancer annonaceous acetogenins.
Jiang S; Li Y; Chen XG; Hu TS; Wu YL; Yao ZJ
Angew Chem Int Ed Engl; 2004 Jan; 43(3):329-34. PubMed ID: 14705089
[No Abstract] [Full Text] [Related]
13. Novel multifunctional acyloxyalkyl ester prodrugs of 5-aminolevulinic acid display improved anticancer activity independent and dependent on photoactivation.
Berkovitch G; Doron D; Nudelman A; Malik Z; Rephaeli A
J Med Chem; 2008 Dec; 51(23):7356-69. PubMed ID: 19007111
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of diarylamines and diarylethers as cytotoxic antitumor agents.
Wang XF; Tian XT; Ohkoshi E; Qin B; Liu YN; Wu PC; Hour MJ; Hung HY; Qian K; Huang R; Bastow KF; Janzen WP; Jin J; Morris-Natschke SL; Lee KH; Xie L
Bioorg Med Chem Lett; 2012 Oct; 22(19):6224-8. PubMed ID: 22932313
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological studies of the thiols-triggered anticancer prodrug for a more effective cancer therapy.
Xu Y; Chen J; Li Y; Peng S; Gu X; Sun M; Gao K; Fang J
Org Biomol Chem; 2015 Mar; 13(9):2634-9. PubMed ID: 25581090
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationship studies of cytotoxic ester and ether anhydrovinblastine derivatives.
Zhang HK; Shao Y; Ding H; Hu LH
J Nat Prod; 2008 Oct; 71(10):1669-76. PubMed ID: 18771244
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel 2',3'-didehydro-2',3'-dideoxyinosine phosphoramidate prodrugs and evaluation of their anticancer activity.
Borek W; Lewandowska M; Kleczewska N; Ruszkowski P; Kacprzak K; Celewicz L
Nucleosides Nucleotides Nucleic Acids; 2014; 33(8):507-18. PubMed ID: 25009986
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia activated prodrugs of a 9-aza-anthrapyrazole derivative that has promising anticancer activity.
El-Dakdouki MH; Adamski N; Foster L; Hacker MP; Erhardt PW
J Med Chem; 2011 Dec; 54(23):8224-7. PubMed ID: 22011244
[TBL] [Abstract][Full Text] [Related]
19. Structure-transfection activity relationships in a series of novel cationic lipids with heterocyclic head-groups.
Ivanova EA; Maslov MA; Kabilova TO; Puchkov PA; Alekseeva AS; Boldyrev IA; Vlassov VV; Serebrennikova GA; Morozova NG; Zenkova MA
Org Biomol Chem; 2013 Nov; 11(41):7164-78. PubMed ID: 24057052
[TBL] [Abstract][Full Text] [Related]
20. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
Sbovata SM; Bettio F; Mozzon M; Bertani R; Venzo A; Benetollo F; Michelin RA; Gandin V; Marzano C
J Med Chem; 2007 Sep; 50(19):4775-84. PubMed ID: 17713897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
